Daniel Grosslight's Stock Ratings

Citigroup Analyst

Daniel Grosslight is an analyst at Citigroup. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

-18.1%

Smart Score

37.9%

Overall Average Return Percentile

13th

Number of Ratings

70
Buy NowGet Alert
04/30/2024MCKBuy Now
McKesson
$562.6610.19%$575 → $620MaintainsBuyGet Alert
04/22/2024PRVABuy Now
Privia Health Gr
$17.0047.06% → $25Initiates → BuyGet Alert
04/22/2024EVHBuy Now
Evolent Health
$23.0073.91% → $40Initiates → BuyGet Alert
04/22/2024AGLBuy Now
Agilon Health
$5.558.11% → $6Initiates → NeutralGet Alert
04/16/2024MEBuy Now
23andMe Holding
$0.60-21.44%$0.85 → $0.47MaintainsNeutralGet Alert
03/20/2024RCMBuy Now
R1 RCM
$12.3129.98% → $16UpgradeNeutral → BuyGet Alert
03/01/2024RCMBuy Now
R1 RCM
$12.3129.98%$14 → $16MaintainsBuyGet Alert
02/27/2024HIMSBuy Now
Hims & Hers Health
$14.1213.31%$12 → $16MaintainsBuyGet Alert
02/21/2024TDOCBuy Now
Teladoc Health
$12.6150.67%$21 → $19MaintainsNeutralGet Alert
02/08/2024MCKBuy Now
McKesson
$562.662.19%$530 → $575MaintainsBuyGet Alert
10/23/2023TDOCBuy Now
Teladoc Health
$12.6166.53%$29 → $21MaintainsNeutralGet Alert
10/20/2023TDOCBuy Now
Teladoc Health
$12.6166.53%$29 → $21MaintainsNeutralGet Alert
09/07/2023PHRBuy Now
Phreesia
$24.0653.78%$40 → $37MaintainsBuyGet Alert
08/10/2023GDRXBuy Now
GoodRx Holdings
$7.5246.28%$7 → $11MaintainsBuyGet Alert
08/10/2023MEBuy Now
23andMe Holding
$0.60192.5%$2.5 → $1.75MaintainsBuyGet Alert
08/09/2023EHTHBuy Now
eHealth
$5.3487.2%$9 → $10MaintainsNeutralGet Alert
08/04/2023MAXBuy Now
MediaAlpha
$18.49-56.73%$7 → $8DowngradeNeutral → SellGet Alert
07/26/2023TDOCBuy Now
Teladoc Health
$12.61129.98%$31 → $29MaintainsNeutralGet Alert
06/12/2023CAHBuy Now
Cardinal Health
$99.27-9.34%$88 → $90MaintainsNeutralGet Alert
05/26/2023MEBuy Now
23andMe Holding
$0.60317.85%$3.75 → $2.5MaintainsNeutralGet Alert
05/11/2023GDRXBuy Now
GoodRx Holdings
$7.52-6.91%$7.5 → $7MaintainsBuyGet Alert
05/08/2023CAHBuy Now
Cardinal Health
$99.27-11.35%$77 → $88MaintainsNeutralGet Alert
05/03/2023ABCBuy Now
AmerisourceBergen
——$185 → $195MaintainsBuyGet Alert
04/28/2023EHTHBuy Now
eHealth
$5.3431.04%$10 → $7MaintainsNeutralGet Alert
04/28/2023SLQTBuy Now
SelectQuote
$2.88-56.67%$1.5 → $1.25MaintainsNeutralGet Alert
04/27/2023TDOCBuy Now
Teladoc Health
$12.61145.84%$30 → $31MaintainsNeutralGet Alert
03/31/2023CAHBuy Now
Cardinal Health
$99.27-22.44% → $77Initiates → NeutralGet Alert
03/31/2023ABCBuy Now
AmerisourceBergen
—— → $185Initiates → BuyGet Alert
03/31/2023MCKBuy Now
McKesson
$562.66-25.36% → $420Initiates → BuyGet Alert
03/24/2023HCATBuy Now
Health Catalyst
$6.95130.22%$17 → $16MaintainsBuyGet Alert

Recent Analyst Stock Rating News

What 12 Analyst Ratings Have To Say About Privia Health Gr
13 Analysts Assess Teladoc Health: What You Need To Know
In-Depth Examination Of 6 Analyst Recommendations For Evolent Health
Where Privia Health Gr Stands With Analysts
Key Takeaways From Agilon Health Analyst Ratings
Breaking Down Hims & Hers Health: 6 Analysts Share Their Views
The Latest Analyst Ratings For R1 RCM
What 9 Analyst Ratings Have To Say About Teladoc Health
Analyst Scoreboard: 12 Ratings For R1 RCM
These Analysts Boost Their Forecasts On Hims & Hers After Upbeat Earnings
Hims & Hers Health, Inc. (NYSE: HIMS) reported better-than-expected fourth-quarter financial results and issued strong guidance on Monday.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free